Alexion Pharmaceuticals Investors
Alexion Pharmaceuticals is a prominent biopharmaceutical company headquartered in Cheshire, Connecticut, United States, established in 1992 The company specializes in the development and commercialization of innovative therapies for rare and complex diseases Alexion has garnered significant investment, reflecting its commitment to advancing medical science and improving patient outcomes With a strong focus on research and development, the company continues to expand its portfolio of life-changing treatments Alexions dedication to addressing unmet medical needs positions it as a leader in the biopharmaceutical industry
Technology:
Anti-infective Drugs
Headquarters:
USA
Last Funding Date:
1999-02-12
Total Funding:
5800000
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
1
Founded Date:
1992
Industry:
FemTech
Employee Number:
1001-5000
Estimated Revenue:
$1B to $10B
Investor Type:
Angel Groups
Funding Status:
M&A